Aprogen Competitors

Stocks . Korea . 
Stock . Aprogen Healthcare Games
109960 Stock  KRW 487.00  11.00  2.21%   
Aprogen Healthcare Games competes with Seoul Semiconductor, SFA Engineering, Busan Industrial, UNISEM, and Finebesteel; as well as few others. The company operates under Communications Equipment sector and is part of Information Technology industry. Analyzing Aprogen Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aprogen Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Aprogen Healthcare Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Aprogen Healthcare competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
484.07487.00489.93
Details
Intrinsic
Valuation
LowRealHigh
454.45457.38535.70
Details
Naive
Forecast
LowNextHigh
470.46473.39476.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
448.85505.93563.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aprogen Healthcare. Your research has to be compared to or analyzed against Aprogen Healthcare's peers to derive any actionable benefits. When done correctly, Aprogen Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aprogen Healthcare Games.

Aprogen Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aprogen Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Aprogen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aprogen Healthcare Games does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
011390
+ 1.0
011390
361580
+ 0.83
046890
361580
+ 0.82
036200
036200
+ 0.71
046890
361580
+ 0.6
056190
036200
+ 0.59
056190
  
High negative correlations   
012450
- 0.91
056190
500003
- 0.84
500015
011390
- 0.71
056190
011390
- 0.71
056190
012450
- 0.64
361580
012450
- 0.56
036200

Risk-Adjusted Indicators

There is a big difference between Aprogen Stock performing well and Aprogen Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aprogen Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
046890  1.79 (0.26) 0.00  1.29  0.00 
 0.00 
 3.51 
(3.22)
 25.37 
056190  1.92 (0.13) 0.00  0.31  0.00 
 0.00 
 2.92 
(4.02)
 13.49 
011390  2.05 (0.08)(0.02) 0.02  2.40 
(2.54)
 4.70 
(4.61)
 24.98 
011390  2.05 (0.08)(0.02) 0.02  2.40 
(2.54)
 4.70 
(4.61)
 24.98 
500015  1.72  0.00  0.00  0.10  0.00 
 0.00 
 2.86 
(4.10)
 8.67 
036200  2.43 (0.35) 0.00  1.85  0.00 
 0.00 
 6.07 
(4.11)
 16.12 
133820  1.81  0.10  0.02  0.37  1.90 
(2.27)
 3.56 
(2.87)
 25.82 
500003  1.70  0.00 (0.02) 0.09  1.89 
(1.94)
 4.16 
(3.07)
 9.46 
361580  0.85 (0.10) 0.00  1.73  0.00 
 0.00 
 2.15 
(2.16)
 5.89 
012450  2.27  0.31  0.08  0.46  2.65 
(3.50)
 7.04 
(3.84)
 23.30 
All Fundamental Data

Aprogen Healthcare Competitive Analysis

The better you understand Aprogen Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aprogen Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aprogen Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
109960 046890 056190 011390 011390 500015 036200 133820 500003 361580
 2.21 
 487.00 
Aprogen
 0.40 
 7,600 
Seoul
 1.44 
 21,200 
SFA
 0.55 
 55,300 
Busan
 0.55 
 55,300 
Busan
 0.55 
 7,185 
Shinhan
 0.52 
 5,780 
UNISEM
 1.31 
 1,051 
Finebesteel
 0.54 
 2,795 
Shinhan
 0.11 
 18,230 
KBSTAR
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Weak
Weak
Very Weak
Very Weak
Insignificant
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
About Average
Low
Low
Low
Unknown
Unknown
Low
Low
Low
Unknown
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Current Ratio
31.11
1.4
3.05
N/A
3.52
N/A
N/A
Net Asset
226.74 B
1.51 T
1.9 T
N/A
232.94 B
183.24 B
N/A
Profit Margin
0.17
0.0495
0.0601
N/A
0.12
0.0673
N/A
EBITDA
(2.33 B)
153.84 B
256.65 B
N/A
48.39 B
15.33 B
N/A
Operating Margin
-0.32
0.0511
0.12
N/A
0.16
0.0934
N/A
Current Valuation
126 B
1.37 T
1.29 T
N/A
388.7 B
138.3 B
N/A
Price To Book
N/A
N/A
N/A
N/A
N/A
0.8
N/A
Retained Earnings
(512 M)
230.13 B
487 B
N/A
32.16 B
N/A
N/A
Current Asset
5.78 B
449.06 B
554.95 B
N/A
60.66 B
N/A
N/A
Beta
1.55
1.07
0.59
N/A
1.45
1.23
N/A
Number Of Employees
15
28
30
N/A
707
2
N/A
Shares Outstanding
178.7 M
58.31 M
34.93 M
N/A
28.91 M
29.78 M
N/A
Cash Flow From Operations
(13.29 B)
98.43 B
56.29 B
N/A
45.18 B
11.17 B
N/A
Annual Yield
N/A
0.0114
0.031
N/A
0.0104
N/A
N/A
Total Debt
37.5 M
195.15 B
114.92 B
N/A
1.85 B
5.09 B
N/A
Return On Equity
3.02
4.3
0.0994
N/A
13.1
0.13
N/A
Z Score
N/A
1.8
6.6
N/A
65.2
7.2
N/A
Return On Asset
-0.0075
0.0343
0.0664
N/A
0.14
0.0502
N/A
Book Value Per Share
346.53
N/A
N/A
N/A
N/A
N/A
N/A
Current Liabilities
5.61 B
343.77 B
293.03 B
N/A
21.04 B
N/A
N/A
Total Asset
226.74 B
1.51 T
1.9 T
N/A
232.94 B
183.24 B
N/A
Debt To Equity
0.002
30.2
0.15
N/A
0.099
N/A
N/A
Target Price
N/A
13786.0
53167.0
N/A
10000.0
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
40.0
N/A
N/A
Shares Owned By Institutions
0.39
8.1
19.1
N/A
5.41
0.01
N/A
Market Capitalization
54.14 B
646.02 B
1.31 T
N/A
197.74 B
63.58 B
N/A
Price To Earning
N/A
39.73
21.45
N/A
57.76
N/A
N/A
Price To Sales
7.7
0.46
0.76
N/A
0.64
0.45
N/A
Net Income
2.65 B
64.4 B
116.86 B
N/A
38.16 B
2.37 B
N/A
Earnings Per Share
N/A
279.3
1348.09
N/A
334.39
N/A
N/A
Shares Owned By Insiders
59.7
31.03
54.02
N/A
29.03
51.0
N/A
Revenue
8.42 B
1.3 T
1.56 T
N/A
296.08 B
124.08 B
N/A
Working Capital
168 M
105.28 B
261.92 B
N/A
39.62 B
N/A
N/A
Cash And Equivalents
11.53 B
86 B
277.02 B
N/A
77.9 B
N/A
N/A
Cash Per Share
175.12
688.81
N/A
N/A
N/A
N/A
N/A
Gross Profit
2.46 B
265.9 B
277.49 B
N/A
73.09 B
11.61 B
N/A
Day Typical Price
494.33
7633.33
20866.67
55433.33
55433.33
7191.67
5793.33
1055.33
2791.67
18218.33
Accumulation Distribution
12990.42
3798.67
7403.54
240.44
240.44
1.4
2304.09
1457.02
118.14
49.05
Market Facilitation Index
1.0E-4
0.0011
0.0077
0.57
0.57
0.0396
0.0014
0.0012
3.0E-4
0.0468
Daily Balance Of Power
(0.50)
0.1667
0.2727
0.1071
0.1071
(2.00)
(0.21)
(0.33)
1.5
0.0976
Period Momentum Indicator
(11.00)
30.0
300.0
300.0
300.0
(40.00)
(30.00)
(14.00)
15.0
20.0
Rate Of Daily Change
0.98
1.0
1.01
1.01
1.01
0.99
0.99
0.99
1.01
1.0
Day Median Price
498.0
7650.0
20700.0
55500.0
55500.0
7195.0
5800.0
1057.5
2790.0
18212.5
Price Action Indicator
(16.50)
(35.00)
650.0
(50.00)
(50.00)
(30.00)
(35.00)
(13.50)
12.5
27.5
Relative Strength Index
29.87
35.2
26.67
54.62
54.62
44.45
36.2
58.62
54.2
29.87
Coefficient Of Variation
(666.63)
(1,145)
(1,667)
10718.43
10718.43
(9,598)
(897.84)
2151.96
3512.47
(1,176)
Mean Deviation
2.09
1.79
1.92
2.05
2.05
1.72
2.43
1.81
1.7
0.849
Jensen Alpha
(0.45)
(0.26)
(0.13)
(0.08)
(0.08)
(0)
(0.35)
0.1014
0.0014
(0.10)
Total Risk Alpha
(0.80)
(0.62)
(0.49)
(0.36)
(0.36)
(0.27)
(0.73)
(0.21)
(0.19)
(0.24)
Sortino Ratio
N/A
N/A
N/A
(0.02)
(0.02)
N/A
N/A
0.0224
(0.02)
N/A
Downside Variance
N/A
N/A
N/A
6.64
6.64
N/A
N/A
4.29
4.26
N/A
Standard Deviation
2.98
3.06
2.79
3.37
3.37
2.12
3.21
3.05
2.16
1.18
Kurtosis
6.36
18.15
3.77
11.86
11.86
(0.40)
0.9088
19.44
(0.05)
1.32
Potential Upside
3.88
3.51
2.92
4.7
4.7
2.86
6.07
3.56
4.16
2.15
Treynor Ratio
4.82
1.29
0.3098
0.0186
0.0186
0.0983
1.85
0.3708
0.0878
1.73
Maximum Drawdown
20.9
25.37
13.49
24.98
24.98
8.67
16.12
25.82
9.46
5.89
Variance
8.9
9.37
7.81
11.36
11.36
4.5
10.32
9.3
4.66
1.39
Market Risk Adjusted Performance
4.83
1.3
0.3198
0.0286
0.0286
0.1083
1.86
0.3808
0.0978
1.74
Risk Adjusted Performance
(0.11)
(0.06)
(0.04)
0.0148
0.0148
(0)
(0.08)
0.0425
0.028
(0.06)
Skewness
(1.34)
2.89
0.1047
2.43
2.43
(0.41)
0.8405
3.2
0.4391
0.0572
Semi Deviation
N/A
N/A
N/A
2.4
2.4
N/A
N/A
1.9
1.89
N/A
Information Ratio
(0.18)
(0.12)
(0.09)
(0.02)
(0.02)
(0.06)
(0.14)
0.0152
(0.02)
(0.17)
Value At Risk
(4.73)
(3.22)
(4.02)
(4.61)
(4.61)
(4.10)
(4.11)
(2.87)
(3.07)
(2.16)
Expected Short fall
N/A
N/A
N/A
(2.54)
(2.54)
N/A
N/A
(2.27)
(1.94)
N/A
Downside Deviation
N/A
N/A
N/A
2.58
2.58
N/A
N/A
2.07
2.06
N/A
Semi Variance
N/A
N/A
N/A
5.74
5.74
N/A
N/A
3.59
3.58
N/A

Aprogen Healthcare Competition Performance Charts

Five steps to successful analysis of Aprogen Healthcare Competition

Aprogen Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aprogen Healthcare Games in relation to its competition. Aprogen Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Aprogen Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aprogen Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aprogen Healthcare Games, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Aprogen Healthcare position

In addition to having Aprogen Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Casinos Thematic Idea Now

Casinos
Casinos Theme
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Aprogen Stock

Aprogen Healthcare financial ratios help investors to determine whether Aprogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aprogen with respect to the benefits of owning Aprogen Healthcare security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY